
What We Learned at ACDM: A Reality Check on AI Adoption in Life Sciences
The ACDM AI/ML Conference, held from June 23- 24 2025 in Frankfurt, Germany, offered a reality check on where the life sciences industry truly stands
A Saama company that offers data analytics solutions and services for banking and capital markets, consumer goods, insurance, the public sector, and more.
Our perspective on AL/ML in the life sciences industry.
The ACDM AI/ML Conference, held from June 23- 24 2025 in Frankfurt, Germany, offered a reality check on where the life sciences industry truly stands
Clinical trials are experiencing a major transformation. While the core goal remains bringing safe, effective treatments to patients, how we reach that goal is changing
When it comes to clinical trial data, consistency is everything. That’s where the Study Data Tabulation Model (SDTM), developed by the Clinical Data Interchange Standards
Healthcare data generates an astonishing 30% of the world’s total data, yet 80% of it remains unstructured- trapped in clinical notes, research papers, and disparate
Artificial Intelligence (AI) and Machine Learning (ML) have become key players in reshaping how we develop drugs, but with this potential comes the critical need
We’ll be covering the best practices for training AI models for life sciences, from data preparation to training methods, and more.
Today we’ll be looking at AI’s applicability across clinical data management (CDM) in life sciences and how it improves CDM as a business process. Artificial Intelligence
No matter what your core focus is as a life sciences organization, manual data review is laborious and time-consuming, and vulnerable to human errors. A
Patients’ safety is the top priority in any clinical trial. The data safety and monitoring services (DSMC) are there to ensure that the clinical studies